Search
Docetaxel anhydrous is used in the treatment of metastatic breast cancer and non-small cell lung cancer. Docetaxel anhydrous inhibits mitosis and proliferation of cancer cells by promoting the assembly of microtubule dimers into microtubules and stabilizing microtubules by preventing the depolymerization process, thereby blocking cells in the G2 and M phases.
Items | Specifications | Results |
Appearance | White or almost white crystalline powder | White crystalline Powder |
Water | ≤3.0% | 1.23% |
Residue of ignition | ≤0.2% | 0.09% |
Heavy metals | ≤20ppm | 10ppm |
Any other single impurity | ≤0.10% | Confirm |
Total impurity | ≤1.0% | Confirm |
Assay (HPLC) | 98.0%—102.0% | 99.56 % |
Product parameters | |
Cas number: | 114977-28-5 |
Appearance: | White or almost white crystalline powder |
Purity: | 98~102% |
Package details: | 10g/bottle; 100g/foil bag |
Brand: | Fortunachem |
Docetaxel has applications in breast cancer and hormone-refractory prostate cancer.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: